Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

DPH 1,695.22 -3.78 (-0.22%)
price chart
Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after ...
Pharmaceutical giants Dechra Pharmaceuticals (LSE: DPH) and GlaxoSmithKline (LSE: GSK) took divergent paths in Monday morning business despite both releasing positive updates.
Dechra Pharmaceuticals PLC: Annual Results  PR Newswire (press release)
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...
Dechra Pharmaceuticals PLC (LSE: symbol DPH) announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine.
Dechra to acquire Putney, maker of generic veterinary drugs, for $200 million  dvm360
OP animal health parent leashes $200M acquisition  Kansas City Business Journal
Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On ...
For example, Dechra (LSE: DPH) has been able to increase its earnings at a double-digit rate in each of the last three years, with it rising at an annualised rate of 23% during the period.
Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc 'buys' after ...
Also reporting today was Dechra Pharmaceuticals (LSE: DPH). Its trading in the most recent full year was strong, with revenue rising by 21%.
Dechra� Pharmaceuticals PLC (LSE symbol DPH) Releases its 2017 Half-yearly ...
Core (excluding acquisitions) European Pharmaceuticals (EU Pharmaceuticals) Segment revenue growth of 5.9% at CER (20.0% at AER).
Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra ...
One of the major concerns of investors in AstraZeneca (LSE: AZN) in recent years has been its ability to pay dividends. That's because it has been subjected to a patent cliff, where a number of key drugs have come off-patent and with the company ...
Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?
Pet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week.
Stock Valuation in Focus for Dechra Pharmaceuticals plc (LSE:DPH)
Dechra Pharmaceuticals plc (LSE:DPH) has an ERP5 rank of 6353. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.
Is Dechra Pharmaceuticals plc's (LSE:DPH) stock available for good price when ...
Dechra Pharmaceuticals plc (LSE:DPH) is considered a high growth stock but some investors are starting to doubt its last closing price of �16.66 can be still justified by the high growth potential.
New Analyst Ratings For Dechra Pharmaceuticals (LON:DPH)  The De Soto Edge
4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals ...
The world of pet healthcare is a fast-growing market, making animal medicines and specialist food producer Dechra Pharmaceuticals (LSE: DPH) a star pick in my opinion. The business saw revenues jump 5.1% during the year ending September, to �203.5m ...